메뉴 건너뛰기




Volumn 74, Issue 2, 2007, Pages 121-132

Mastocytosis: State of the art

Author keywords

Bone marrow; Immunohistochemistry; Mast cell; Mastocytosis; Systemic mastocytosis

Indexed keywords

CD2 ANTIGEN; CD34 ANTIGEN; IMATINIB; INTERLEUKIN 2 RECEPTOR ALPHA; STEM CELL FACTOR RECEPTOR; TRYPTASE;

EID: 34250796815     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101711     Document Type: Review
Times cited : (216)

References (62)
  • 2
    • 0028881815 scopus 로고
    • The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
    • Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, Metcalfe DD: The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-2710.
    • (1995) J Clin Invest , vol.96 , pp. 2702-2710
    • Schwartz, L.B.1    Sakai, K.2    Bradford, T.R.3    Ren, S.4    Zweiman, B.5    Worobec, A.S.6    Metcalfe, D.D.7
  • 3
    • 18444416819 scopus 로고    scopus 로고
    • Serum tryptase levels in patients with mastocytosis: Correlation with mast cell burden and implication for defining the category of disease
    • Sperr WR, Jordan JH, Fiegl M, Escribano L, Dirnhofer S, Semper H, et al: Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol 2002;128:136-141.
    • (2002) Int Arch Allergy Immunol , vol.128 , pp. 136-141
    • Sperr, W.R.1    Jordan, J.H.2    Fiegl, M.3    Escribano, L.4    Dirnhofer, S.5    Semper, H.6
  • 4
    • 0026546811 scopus 로고
    • Effects of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells
    • Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD: Effects of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol 1992;148:772-777.
    • (1992) J Immunol , vol.148 , pp. 772-777
    • Kirshenbaum, A.S.1    Goff, J.P.2    Kessler, S.W.3    Mican, J.M.4    Zsebo, K.M.5    Metcalfe, D.D.6
  • 6
    • 0026801434 scopus 로고
    • Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit ligand in long-term culture
    • Valent P, Spanblöchl E, Sperr WR, Sillaber CH, Agis H, Zsebo K, et al: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit ligand in long-term culture. Blood 1992;80:2237-2245.
    • (1992) Blood , vol.80 , pp. 2237-2245
    • Valent, P.1    Spanblöchl, E.2    Sperr, W.R.3    Sillaber, C.H.4    Agis, H.5    Zsebo, K.6
  • 7
    • 0034983239 scopus 로고    scopus 로고
    • Morphologic properties of neoplastic mast cells: Delineation of stages of maturation and implication for cytological grading of mastocytosis
    • Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny H-P, Valent P: Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001;25:529-536.
    • (2001) Leuk Res , vol.25 , pp. 529-536
    • Sperr, W.R.1    Escribano, L.2    Jordan, J.H.3    Schernthaner, G.H.4    Kundi, M.5    Horny, H.-P.6    Valent, P.7
  • 9
    • 0034983045 scopus 로고    scopus 로고
    • Valent P, Horny H-P, Escribano L, Longley JB, Li CY, Schwartz LB, et al: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Conference Report of 'Year 2000 Working Conference on Mastocytosis'. Leuk Res 2001;25:603-625.
    • Valent P, Horny H-P, Escribano L, Longley JB, Li CY, Schwartz LB, et al: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Conference Report of 'Year 2000 Working Conference on Mastocytosis'. Leuk Res 2001;25:603-625.
  • 10
    • 0141506139 scopus 로고    scopus 로고
    • Mast cell proliferative disorders: Current view on variants recognized by the World Health Organization
    • Valent P, Akin C, Sperr WR, Horny H-P, Metcalfe DD: Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. Hematol Oncol Clin North Am 2003;17:1227-1241.
    • (2003) Hematol Oncol Clin North Am , vol.17 , pp. 1227-1241
    • Valent, P.1    Akin, C.2    Sperr, W.R.3    Horny, H.-P.4    Metcalfe, D.D.5
  • 11
    • 0034986344 scopus 로고    scopus 로고
    • Diagnosis of mastocytosis: General histopathological aspects, morphological criteria, and immunohistochemical findings
    • Horny H-P, Valent P: Diagnosis of mastocytosis: General histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 2001;25:543-551.
    • (2001) Leuk Res , vol.25 , pp. 543-551
    • Horny, H.-P.1    Valent, P.2
  • 12
    • 0042090516 scopus 로고    scopus 로고
    • Increase of bone marrow lymphocytes in systemic mastocytosis: Reactive lymphocytosis or malignant lymphoma? Immuno-histochemical and molecular findings on routinely processed bone marrow biopsy specimens
    • Horny H-P, Lange K, Sotlar K, Valent P: Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immuno-histochemical and molecular findings on routinely processed bone marrow biopsy specimens. J Clin Pathol 2003;56:575-578.
    • (2003) J Clin Pathol , vol.56 , pp. 575-578
    • Horny, H.-P.1    Lange, K.2    Sotlar, K.3    Valent, P.4
  • 13
    • 0036119421 scopus 로고    scopus 로고
    • Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): Histopathologic and morphologic evaluation with special reference to novel SM criteria
    • Jordan JH, Sperr WR, Lechner K, Geissler K, Schernthaner G-H, Fritsche-Polanz R, et al: Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to novel SM criteria. Leuk Lymphoma 2002;43:575-582.
    • (2002) Leuk Lymphoma , vol.43 , pp. 575-582
    • Jordan, J.H.1    Sperr, W.R.2    Lechner, K.3    Geissler, K.4    Schernthaner, G.-H.5    Fritsche-Polanz, R.6
  • 15
    • 0034982081 scopus 로고    scopus 로고
    • Diagnosis of mastocytosis: Value of cytochemistry and immunohistochemistry
    • Li C-Y: Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry. Leuk Res 2001;25:537-541.
    • (2001) Leuk Res , vol.25 , pp. 537-541
    • Li, C.-Y.1
  • 16
    • 5044230101 scopus 로고    scopus 로고
    • CD25 indicates the neoplastic phenotype of mast cells: A novel immunohistochemical marker for the diagnosis of systemic mastocytosis in routinely processed bone marrow biopsy specimens
    • Sotlar K, Horny H-P, Simonitsch I, Krokowski M, Aichberger KJ, Mayerhofer M, Printz D, Fritsch G, Valent P: CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 2004;28:1319-1325.
    • (2004) Am J Surg Pathol , vol.28 , pp. 1319-1325
    • Sotlar, K.1    Horny, H.-P.2    Simonitsch, I.3    Krokowski, M.4    Aichberger, K.J.5    Mayerhofer, M.6    Printz, D.7    Fritsch, G.8    Valent, P.9
  • 17
    • 0034987361 scopus 로고    scopus 로고
    • Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: Evidence for expression of CD2, CD117/Kit, and bcl-xL
    • Jordan H, Walchshofer S, Jurecka W, Mosberger I, Sperr WR, Wolff K, et al: Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-xL. Hum Pathol 2001;32:545-552.
    • (2001) Hum Pathol , vol.32 , pp. 545-552
    • Jordan, H.1    Walchshofer, S.2    Jurecka, W.3    Mosberger, I.4    Sperr, W.R.5    Wolff, K.6
  • 18
    • 0344643427 scopus 로고    scopus 로고
    • Sotlar K, Escribano L, Landt O, Möhrle S, Herrero S, Torrelo A, Lass ,Horny H-P, Bültmann B: One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 2003;162:737-746.
    • Sotlar K, Escribano L, Landt O, Möhrle S, Herrero S, Torrelo A, Lass ,Horny H-P, Bültmann B: One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 2003;162:737-746.
  • 19
    • 0033867827 scopus 로고    scopus 로고
    • Detection of c-kit mutation Asp-816-Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukemia
    • Sotlar K, Marafioti T, Griesser H, Theil J, Aepinus C, Jaussi R, et al: Detection of c-kit mutation Asp-816-Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukemia. Mol Pathol 2000;53:188-193.
    • (2000) Mol Pathol , vol.53 , pp. 188-193
    • Sotlar, K.1    Marafioti, T.2    Griesser, H.3    Theil, J.4    Aepinus, C.5    Jaussi, R.6
  • 20
    • 0028856070 scopus 로고
    • Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
    • Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-10564.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 10560-10564
    • Nagata, H.1    Worobec, A.S.2    Oh, C.K.3    Chowdhury, B.A.4    Tannenbaum, S.5    Suzuki, Y.6    Metcalfe, D.D.7
  • 21
    • 0009013631 scopus 로고    scopus 로고
    • Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
    • Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, et al: Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-314.
    • (1996) Nat Genet , vol.12 , pp. 312-314
    • Longley, B.J.1    Tyrrell, L.2    Lu, S.Z.3    Ma, Y.S.4    Langley, K.5    Ding, T.G.6
  • 22
    • 13044305857 scopus 로고    scopus 로고
    • Activating and dominant inactivating c-kit catalytic domain mutations in distinct forms of human mastocytosis
    • Longley BJ, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu S-Z, et al: Activating and dominant inactivating c-kit catalytic domain mutations in distinct forms of human mastocytosis. Proc Natl Acad Sci USA 1999;96:1609-1614.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 1609-1614
    • Longley, B.J.1    Metcalfe, D.D.2    Tharp, M.3    Wang, X.4    Tyrrell, L.5    Lu, S.-Z.6
  • 23
    • 0036207241 scopus 로고    scopus 로고
    • Kit and c-kit mutations in mastocytosis: A short overview with special reference to novel molecular and diagnostic concepts
    • Feger F, Ribadeau Dumas A, Leriche L, Valent P, Arock M: Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts. Int Arch Allergy Immunol 2002;127:110-114.
    • (2002) Int Arch Allergy Immunol , vol.127 , pp. 110-114
    • Feger, F.1    Ribadeau Dumas, A.2    Leriche, L.3    Valent, P.4    Arock, M.5
  • 24
    • 0034993741 scopus 로고    scopus 로고
    • Classes of c-KIT activating mutations: Proposed mechanisms of action and implications for disease classification and therapy
    • Longley BJ, Reguera MJ, Ma Y: Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leuk Res 2001;25:571-576.
    • (2001) Leuk Res , vol.25 , pp. 571-576
    • Longley, B.J.1    Reguera, M.J.2    Ma, Y.3
  • 27
    • 1542407188 scopus 로고    scopus 로고
    • Acute myeloid leukaemia with t(8; 21) associated with 'occult' mastocytosis. Report of an unusual case and review of the literature
    • Bernd HW, Sotlar K, Lorenzen J, Osieka R, Fabry U, Valent P, Horny H-P: Acute myeloid leukaemia with t(8; 21) associated with 'occult' mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol 2004;57:324-328.
    • (2004) J Clin Pathol , vol.57 , pp. 324-328
    • Bernd, H.W.1    Sotlar, K.2    Lorenzen, J.3    Osieka, R.4    Fabry, U.5    Valent, P.6    Horny, H.-P.7
  • 29
    • 33344465478 scopus 로고    scopus 로고
    • KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired eventfree and overall survival
    • Schnittger S, Kohl TM, Haferlach T, Kern W, Hiddemann W, Spiekermann K, Schoch C: KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired eventfree and overall survival. Blood 2006;107:1791-1799.
    • (2006) Blood , vol.107 , pp. 1791-1799
    • Schnittger, S.1    Kohl, T.M.2    Haferlach, T.3    Kern, W.4    Hiddemann, W.5    Spiekermann, K.6    Schoch, C.7
  • 30
    • 1842579440 scopus 로고    scopus 로고
    • A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib
    • Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD: A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib. Blood 2004;103:3222-3225.
    • (2004) Blood , vol.103 , pp. 3222-3225
    • Akin, C.1    Fumo, G.2    Yavuz, A.S.3    Lipsky, P.E.4    Neckers, L.5    Metcalfe, D.D.6
  • 32
    • 0034994550 scopus 로고    scopus 로고
    • Clinical and histopathological aspects of cutaneous mastocytosis
    • Wolff K, Komar M, Petzelbauer P: Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res 2001;25:519-528.
    • (2001) Leuk Res , vol.25 , pp. 519-528
    • Wolff, K.1    Komar, M.2    Petzelbauer, P.3
  • 33
    • 0036202127 scopus 로고    scopus 로고
    • Cutaneous mastocytosis - clinical heterogeneity
    • Hartmann K, Henz BM: Cutaneous mastocytosis - clinical heterogeneity. Int Arch Allergy Immunol 2002;127:143-146.
    • (2002) Int Arch Allergy Immunol , vol.127 , pp. 143-146
    • Hartmann, K.1    Henz, B.M.2
  • 34
    • 0032523149 scopus 로고    scopus 로고
    • Indolent systemic mast cell disease in adults: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implication
    • Escribano L, Orfao A, Diaz-Agustin B, Villarrubia J, Cervero C, Lopez A, et al: Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implication. Blood 1998;91:2731-2736.
    • (1998) Blood , vol.91 , pp. 2731-2736
    • Escribano, L.1    Orfao, A.2    Diaz-Agustin, B.3    Villarrubia, J.4    Cervero, C.5    Lopez, A.6
  • 35
    • 0345772088 scopus 로고    scopus 로고
    • Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria
    • Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, Bennett JM, Metcalfe DD: Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 2003;27:635-641.
    • (2003) Leuk Res , vol.27 , pp. 635-641
    • Valent, P.1    Akin, C.2    Sperr, W.R.3    Escribano, L.4    Arock, M.5    Horny, H.P.6    Bennett, J.M.7    Metcalfe, D.D.8
  • 37
    • 2642581620 scopus 로고    scopus 로고
    • Valent P: Systemic mastocytosis with associated clonal haematological non-mast cell lineage disease (SM-AHNMD): a histopathological challenge
    • Horny H-P, Sotlar K, Sperr WR, Valent P: systemic mastocytosis with associated clonal haematological non-mast cell lineage disease (SM-AHNMD): a histopathological challenge. J Clin Pathol 2004;57:604-608.
    • (2004) J Clin Pathol , vol.57 , pp. 604-608
    • Horny, H.-P.1    Sotlar, K.2    Sperr, W.R.3
  • 38
    • 0025114710 scopus 로고
    • Blood findings in generalized mastocytosis: Evidence of frequent simultaneous occurrence of myeloproliferative disorders
    • Horny H-P, Ruck M, Wehrmann M, Kaiserling E: Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haematol 1990;76:186-193.
    • (1990) Br J Haematol , vol.76 , pp. 186-193
    • Horny, H.-P.1    Ruck, M.2    Wehrmann, M.3    Kaiserling, E.4
  • 39
    • 0034050944 scopus 로고    scopus 로고
    • Clinical and biologic diversity of leukemias occurring in patients with mastocytosis
    • Sperr WR, Horny H-P, Lechner K, Valent P: Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma 2000;37:473-486.
    • (2000) Leuk Lymphoma , vol.37 , pp. 473-486
    • Sperr, W.R.1    Horny, H.-P.2    Lechner, K.3    Valent, P.4
  • 40
    • 0346880065 scopus 로고    scopus 로고
    • Clinical, genetic, and therapeutic insights into systemic mast cell disease
    • Tefferi A, Pardanani A: Clinical, genetic, and therapeutic insights into systemic mast cell disease. Curr Opin Hematol 2004;11:58-64.
    • (2004) Curr Opin Hematol , vol.11 , pp. 58-64
    • Tefferi, A.1    Pardanani, A.2
  • 41
    • 0033956308 scopus 로고    scopus 로고
    • Analysis of the surface expression of c-kit and the c-kit Asp816Val activating mutationin T cells, B cells, and myelomonocytic cells in patients with mastocytosis
    • Akin C, Kirshenbaum AS, Semere T, Worobec AS, Scott LM, Mwetcalfe DD: Analysis of the surface expression of c-kit and the c-kit Asp816Val activating mutationin T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol 2000;28:140-147.
    • (2000) Exp Hematol , vol.28 , pp. 140-147
    • Akin, C.1    Kirshenbaum, A.S.2    Semere, T.3    Worobec, A.S.4    Scott, L.M.5    Mwetcalfe, D.D.6
  • 46
    • 0034986351 scopus 로고    scopus 로고
    • Slowly progressing mastocytosis with high mast cell burden and no evidence of a non-mast cell hematologic disorder: An example of a smoldering case?
    • Akin C, Scott LM, Metcalfe DD: Slowly progressing mastocytosis with high mast cell burden and no evidence of a non-mast cell hematologic disorder: an example of a smoldering case? Leuk Res 2001;25:635-638.
    • (2001) Leuk Res , vol.25 , pp. 635-638
    • Akin, C.1    Scott, L.M.2    Metcalfe, D.D.3
  • 47
    • 0034991021 scopus 로고    scopus 로고
    • A case of smouldering mastocytosis with high mast cell burden, monoclonal myeloid cells, and c-kit mutation Asp-816-Val
    • Jordan JH, Fritsche-Polanz R, Sperr WR, Mitterbauer G, Födinger M, Schernthaner GH, et al: A case of smouldering mastocytosis with high mast cell burden, monoclonal myeloid cells, and c-kit mutation Asp-816-Val. Leuk Res 2001;25:627-634.
    • (2001) Leuk Res , vol.25 , pp. 627-634
    • Jordan, J.H.1    Fritsche-Polanz, R.2    Sperr, W.R.3    Mitterbauer, G.4    Födinger, M.5    Schernthaner, G.H.6
  • 48
    • 24544477120 scopus 로고    scopus 로고
    • Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxis
    • Akin C, Metcalfe DD: Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxis. J Allergy Clin Immunol 2003;111:S206.
    • (2003) J Allergy Clin Immunol , vol.111
    • Akin, C.1    Metcalfe, D.D.2
  • 49
    • 33747071501 scopus 로고    scopus 로고
    • Occult' mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis
    • Sotlar K, Saeger W, Stellmacher F, Stahmer J, Jäckle S, Valent P, Horny H-P: 'Occult' mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis. J Clin Pathol 2006;59:875-878.
    • (2006) J Clin Pathol , vol.59 , pp. 875-878
    • Sotlar, K.1    Saeger, W.2    Stellmacher, F.3    Stahmer, J.4    Jäckle, S.5    Valent, P.6    Horny, H.-P.7
  • 50
    • 85047685367 scopus 로고    scopus 로고
    • Myelomastocytic leukemia: Myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells
    • Valent P, Samorapoompichit P, Sperr WR, Horny H-P, Lechner K: Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. Hematol J 2002;3:90-94.
    • (2002) Hematol J , vol.3 , pp. 90-94
    • Valent, P.1    Samorapoompichit, P.2    Sperr, W.R.3    Horny, H.-P.4    Lechner, K.5
  • 51
    • 0035496941 scopus 로고    scopus 로고
    • Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia
    • Sperr WR, Jordan JH, Baghestanian M, Kiener H, Samorapoompichit P, Semper H, et al: Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001;98:2200-2209.
    • (2001) Blood , vol.98 , pp. 2200-2209
    • Sperr, W.R.1    Jordan, J.H.2    Baghestanian, M.3    Kiener, H.4    Samorapoompichit, P.5    Semper, H.6
  • 52
    • 33644763309 scopus 로고    scopus 로고
    • The tryptase-positive compact round cell infiltrate of the bone marrow (TROCI-bm): A novel histopathological finding requiring the application of lineage specific markers
    • Horny H-P, Sotlar K, Stellmacher F, Krokowski M, Agis H, Schwartz LB, Valent P: The tryptase-positive compact round cell infiltrate of the bone marrow (TROCI-bm): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 2006;59:98-302.
    • (2006) J Clin Pathol , vol.59 , pp. 98-302
    • Horny, H.-P.1    Sotlar, K.2    Stellmacher, F.3    Krokowski, M.4    Agis, H.5    Schwartz, L.B.6    Valent, P.7
  • 54
    • 0033945410 scopus 로고    scopus 로고
    • Treatment of systemic mast cell disorders
    • Worobec AS: Treatment of systemic mast cell disorders. Hematol Oncol North Am 2000;14:659-687.
    • (2000) Hematol Oncol North Am , vol.14 , pp. 659-687
    • Worobec, A.S.1
  • 56
    • 0036454699 scopus 로고    scopus 로고
    • Treatment of adult systemic mastocytosis with interferon-alpha: Results of a multicentre phase II trial on 20 patients
    • Casassus P, Caillat-Vigneron N, Martin A, Simon J, Gallais V, Beaudry P, et al: Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients. Br J Haematol 2002;119:1090-1097.
    • (2002) Br J Haematol , vol.119 , pp. 1090-1097
    • Casassus, P.1    Caillat-Vigneron, N.2    Martin, A.3    Simon, J.4    Gallais, V.5    Beaudry, P.6
  • 57
    • 0031943841 scopus 로고    scopus 로고
    • Response of severe systemic mastocytosis to interferon-α
    • Butterfield JH: Response of severe systemic mastocytosis to interferon-α. Br J Dermatol 1998;138:489-495.
    • (1998) Br J Dermatol , vol.138 , pp. 489-495
    • Butterfield, J.H.1
  • 58
    • 0346154747 scopus 로고    scopus 로고
    • Response to therapy with interferonalpha-2b and prednisolone in aggressive systemic mastocytosis: Report of five cases and review of the literature
    • Hauswirth AW, Simonitsch-Klupp I, Uffmann M, Koller E, Sperr WR, Lechner K, Valent P: Response to therapy with interferonalpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature. Leuk Res 2004;28:249-257.
    • (2004) Leuk Res , vol.28 , pp. 249-257
    • Hauswirth, A.W.1    Simonitsch-Klupp, I.2    Uffmann, M.3    Koller, E.4    Sperr, W.R.5    Lechner, K.6    Valent, P.7
  • 60
    • 0345734183 scopus 로고    scopus 로고
    • Treatment of systemic mast cell disease: Beyond interferon
    • Tefferi A: Treatment of systemic mast cell disease: beyond interferon. Leuk Res 2004;28:223-224.
    • (2004) Leuk Res , vol.28 , pp. 223-224
    • Tefferi, A.1
  • 61
    • 10744228486 scopus 로고    scopus 로고
    • CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
    • Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM, et al: CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood 2003;102:3093-3096.
    • (2003) Blood , vol.102 , pp. 3093-3096
    • Pardanani, A.1    Ketterling, R.P.2    Brockman, S.R.3    Flynn, H.C.4    Paternoster, S.F.5    Shearer, B.M.6
  • 62
    • 27144506215 scopus 로고    scopus 로고
    • Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
    • Gotlib J, Berube C, Growney JD, et al: Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005;106:2865-2870.
    • (2005) Blood , vol.106 , pp. 2865-2870
    • Gotlib, J.1    Berube, C.2    Growney, J.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.